Importance of antithrombin evaluation and supplementation in clinical practice
Medicinska istrazivanja · 2025
DOI: 10.5937/medi0-56422 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medicinska istrazivanja, 2025. Verfasst von Nebojša Antonijević und 12 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Antithrombin (AT) is a key natural anticoagulant that primarily inhibits thrombin, factor Xa, and other procoagulant proteases, maintaining hemo-static balance. Deficiency in AT, whether inherited or acquired, significantly increases the risk of venous thromboembolism, obstetric complications and sporadically arterial thrombosis. Individuals with AT deficiency are 15 times more likely to develop thrombosis. Acquired deficiency is more common and may result from hypoproduction, excessive excretion or loss, increased consumption, or dilution of AT. In critically ill patients, acquired antithrombin deficiency may occur frequently; however, routine monitoring of antithrombin levels is not currently supported by strong evidence and should be reserved for selected clinical indications, especially with risk of thromboembolism. Antithrombin is essential for the action of unfractionated heparin, low-molecular-weight heparin, and fondaparinux, meaning deficiency can lead to resistance to these anticoagulants. Antithrombin deficiency is often detected in cases of resistance during the administration of antithrombin-dependent anticoagulants, typically indicated by insufficient levels of anti-Xa activity. Supplementation of AT is indicated for preventing and treating thrombotic events in patients with congenital or acquired AT deficiencies. Supratherapeutic antithrombin levels during heparin therapy can lead to bleeding. Its role in thromboembolism, anticoagulant resistance, and pleiotropic effects highlights its clinical importance and research potential.
Zitieren
APA
Antonijević, N., Tasić, A., Janković, Z., Obradović, V., Đukić, M., Savić, P., Aleksandrić, S., Birovljev, L., Leković, Ž., Ušćumlić, A., Matić, D., Bukarica-Gojković, L., & Kanjuh, V. (2025). Importance of antithrombin evaluation and supplementation in clinical practice. Medicinska istrazivanja. https://doi.org/10.5937/medi0-56422
Vancouver
Antonijević N, Tasić A, Janković Z, Obradović V, Đukić M, Savić P, et al. Importance of antithrombin evaluation and supplementation in clinical practice. Medicinska istrazivanja. 2025. doi:10.5937/medi0-56422
BibTeX
@article{Antonijevi2025,
author = {Antonijević, Nebojša and Tasić, Ana and Janković, Zorana and Obradović, Vanja and Đukić, Marija and Savić, Predrag and Aleksandrić, Srđan and Birovljev, Ljubica and Leković, Žaklina and Ušćumlić, Ana and Matić, Dragan and Bukarica-Gojković, Ljiljana and Kanjuh, Vladimir},
title = {Importance of antithrombin evaluation and supplementation in clinical practice},
journal = {Medicinska istrazivanja},
year = {2025},
doi = {10.5937/medi0-56422}
}
EUVIMED